| LLY |
Eli Lilly and Company |
829.40B |
18.35% |
|
|
|
|
|
873.68 |
0.06% |
29.54% |
16.87% |
|---|
| BMY |
Bristol-Myers Squibb Company |
113.30B |
7.03% |
|
|
|
|
|
55.83 |
0.07% |
28.93% |
31.18% |
|---|
| NVS |
Novartis AG |
215.98B |
6.59% |
|
|
|
|
|
109.35 |
1.90% |
25.57% |
98.38% |
|---|
| AMGN |
Amgen Inc. |
162.78B |
6.15% |
|
|
|
|
|
303.01 |
1.71% |
21.37% |
8.26% |
|---|
| AZN |
AstraZeneca PLC |
230.17B |
5.78% |
|
|
|
|
|
74.22 |
0.97% |
23.61% |
38.39% |
|---|
| USBGFS7 |
US BANK MMDA - USBGFS 7 06/01/2031 |
|
5.21% |
|
|
|
|
|
|
|
|
|
|---|
| JNJ |
Johnson & Johnson |
390.76B |
5.17% |
|
|
|
|
|
162.30 |
1.64% |
18.93% |
38.45% |
|---|
| PFE |
Pfizer Inc. |
149.04B |
4.83% |
|
|
|
|
|
26.30 |
1.54% |
29.55% |
69.99% |
|---|
| ALNY |
Alnylam Pharmaceuticals, Inc. |
32.44B |
4.80% |
|
|
|
|
|
250.59 |
-0.16% |
41.52% |
33.50% |
|---|
| ALKS |
Alkermes plc |
5.74B |
4.68% |
|
|
|
|
|
35.32 |
-0.51% |
55.46% |
54.71% |
|---|
| MRK |
Merck & Co., Inc. |
226.40B |
4.67% |
|
|
|
|
|
89.50 |
2.08% |
29.16% |
71.04% |
|---|
| REGN |
Regeneron Pharmaceuticals, Inc. |
75.29B |
3.57% |
|
|
|
|
|
700.33 |
0.62% |
36.18% |
59.68% |
|---|
| BIIB |
Biogen Inc. |
20.59B |
3.31% |
|
|
|
|
|
140.64 |
2.59% |
37.81% |
56.88% |
|---|
| IONS |
Ionis Pharmaceuticals, Inc. |
5.10B |
3.08% |
|
|
|
|
|
32.32 |
-1.13% |
57.02% |
68.51% |
|---|
| CRSP |
CRISPR Therapeutics AG |
4.11B |
2.88% |
|
|
|
|
|
47.87 |
-5.07% |
61.54% |
46.80% |
|---|
| GSK |
GSK plc |
74.78B |
2.68% |
|
|
|
|
|
36.64 |
0.22% |
22.20% |
50.58% |
|---|
| BEAM |
Beam Therapeutics Inc. |
2.52B |
1.71% |
|
|
|
|
|
30.43 |
-8.18% |
63.92% |
88.15% |
|---|
| BCYC |
Bicycle Therapeutics plc |
804.73M |
1.44% |
|
|
|
|
|
11.66 |
-2.83% |
250.22% |
38.81% |
|---|
| REPL |
Replimune Group, Inc. |
1.08B |
1.25% |
|
|
|
|
|
13.98 |
-2.31% |
122.01% |
11.97% |
|---|
| NTLA |
Intellia Therapeutics, Inc. |
1.24B |
1.16% |
|
|
|
|
|
12.17 |
-0.65% |
84.48% |
67.28% |
|---|
| HLN |
Haleon plc |
45.63B |
0.95% |
|
|
|
|
|
10.08 |
1.82% |
54.43% |
9.48% |
|---|
| VNDA |
Vanda Pharmaceuticals Inc. |
258.34M |
0.87% |
|
|
|
|
|
4.43 |
-1.34% |
86.92% |
44.11% |
|---|
| LTRN |
Lantern Pharma Inc. |
46.70M |
0.67% |
|
|
|
|
|
4.33 |
0.00% |
118.31% |
46.86% |
|---|
| SDZNY |
Sandoz Group AG |
|
0.56% |
|
|
|
|
|
|
|
|
|
|---|
| GEHC |
GE HealthCare Technologies Inc. |
41.62B |
0.53% |
|
|
|
|
|
91.09 |
-1.09% |
24.75% |
28.16% |
|---|
| GALT |
Galectin Therapeutics Inc. |
92.84M |
0.42% |
|
|
|
|
|
1.4900 |
1.36% |
302.34% |
12.34% |
|---|
| TSVT |
2seventy bio, Inc. |
134.65M |
0.35% |
|
|
|
|
|
2.6100 |
-2.61% |
368.39% |
25.60% |
|---|
| VTRS |
Viatris Inc. |
13.43B |
0.31% |
|
|
|
|
|
11.25 |
1.72% |
30.87% |
85.75% |
|---|
| ALLO |
Allogene Therapeutics, Inc. |
454.99M |
0.29% |
|
|
|
|
|
2.1700 |
-3.77% |
677.77% |
87.67% |
|---|
| EDIT |
Editas Medicine, Inc. |
158.49M |
0.27% |
|
|
|
|
|
1.9200 |
-6.80% |
146.68% |
73.44% |
|---|
| PACB |
Pacific Biosciences of California, Inc. |
421.75M |
0.15% |
|
|
|
|
|
1.5400 |
-6.10% |
120.73% |
39.24% |
|---|
| Cash&Other |
Cash & Other |
|
0.14% |
|
|
|
|
|
|
|
|
|
|---|
| BLUE |
bluebird bio, Inc. |
39.67M |
0.10% |
|
|
|
|
|
4.08 |
-42.05% |
122.15% |
19.19% |
|---|
| MURA |
Mural Oncology plc |
69.09M |
0.05% |
|
|
|
|
|
4.05 |
-4.03% |
394.12% |
54.53% |
|---|
| SLRX |
Salarius Pharmaceuticals, Inc. |
2.12M |
0.04% |
|
|
|
|
|
1.3400 |
-0.74% |
N/A |
N/A |
|---|
| 2368714D |
Pathos AI Inc |
|
N/A |
|
|
|
|
|
|
|
|
|
|---|